Import policy interpretation: Vitamin B-1 was read to include thiamine salt forms, with redemption fine moderated for ambiguity.

An import policy entry for Vitamin B-1 was construed to include its commercially available salt forms, namely Thiamine Hydrochloride and Thiamine Mono-nitrate, because trade and technical understanding showed Thiamine as a generic term covering those forms. The later public notice was treated as clarificatory rather than as introducing new commodities, so the imports were regarded as falling within the canalised entry and not covered by a valid import licence. On penalty, the presence of genuine interpretative ambiguity and uneven contemporaneous administrative views justified moderation, and the redemption fine was reduced while the finding of unauthorised importation was maintained.

---

---

Issues: (i) Whether Thiamine Hydrochloride and Thiamine Mono-nitrate fell within the canalised entry of Vitamin B-1 under the import policy and were therefore not covered by a valid import licence; (ii) whether the redemption fine imposed was excessive in the circumstances.

Issue (i): Whether Thiamine Hydrochloride and Thiamine Mono-nitrate fell within the canalised entry of Vitamin B-1 under the import policy and were therefore not covered by a valid import licence.

Analysis: The relevant policy entry had to be construed in the light of the commercial and technical understanding of Vitamin B-1. The materials relied upon showed that Thiamine is a generic term and that its commercially available forms include Thiamine Hydrochloride and Thiamine Mono-nitrate. The policy language, read with the contemporaneous treatment of the item in import policy materials and the earlier view of the Tribunal in a connected matter, supported the conclusion that canalisation of Vitamin B-1 extended to its available salt forms. The subsequent public notice was treated as clarificatory in character rather than as introducing wholly new commodities.

Conclusion: Both Thiamine Hydrochloride and Thiamine Mono-nitrate were covered by Vitamin B-1, and the imports were not under a valid licence because they were canalised items.

Issue (ii): Whether the redemption fine imposed was excessive in the circumstances.

Analysis: The record showed genuine scope for two interpretations of the policy entry, and the contemporaneous administrative views were not uniform. In that setting, the confiscation finding was sustained, but the quantum of fine required moderation. The circumstances justified reduction of the fine while maintaining the adverse finding on importability.

Conclusion: The redemption fine was reduced to 25% of the C.I.F. value, with consequential relief to the appellants.

Final Conclusion: The imports were held to be unauthorised under the canalised policy entry, but the penalty burden was substantially moderated by reducing the redemption fine and granting consequential relief.

Ratio Decidendi: Where an import policy entry refers to a chemically named item that is commercially available only in specific salt forms, the entry may be construed to include those commercially available forms if the policy context and trade understanding so require; however, genuine ambiguity can justify reduction of redemption fine while preserving the substantive finding of breach.

---